Biophan Technologies, Inc. was Issued Two New U.S. Patents Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biophan Technologies, Inc. was Issued Two New U.S. Patents

BIPH 16.60

0.0%

3:45 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: siamese1	2/28/2005 12:00:05 PM
	Read Replies (1) of 10

Biophan Technologies, Inc., a developer of next generation biomedical technology, today announced completion of the acquisition of a majority interest in AMRIS GmbH, bringing Biophan exclusive access to key patents in Magnetic Resonance Imaging (MRI) technology... and a world renowned scientific staff. AMRIS, a leading innovator in MRI-safe and image compatible medical devices and technology solutions, possesses a suite of technology patents that enable effective MRI imaging of a range of important medical devices,including stents and other vascular implants. The newly acquired AMRIS will be renamed Biophan-Europe and will serve as Biophan's chief European marketing and research presence.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next